-
200,000 "frozen people" gospel! Domestic innovative therapeutic drugs have been approved for market
Time of Update: 2020-11-16
Sound Pharmaceuticals was approved this time is also the world's second, domestic first listed Ida Lafeng injection, because the drug has been used for a long time to treat acute ischemic stroke, has accumulated a large number of clinical experience, good safety.
-
The new gCP showcases a number of new changes In the industry
Time of Update: 2020-08-03
With the implementation of the new revision of the Drug Administration Law at the end of 2019, the State Bureau will introduce supporting regulations, working papers and related guidelines in accordan
-
Three drugs of texel applied for certification in FDA
Time of Update: 2020-04-03
Tianshili's 2013 half year report once pointed out that during the period, the company further promoted the phase III clinical trial of Compound Danshen Dropping Pills in the United States, and the tw
-
6-pound drug will be listed on the market as a new rare disease drug and over 1 billion injections
Time of Update: 2019-01-14
Highlights: 1 Another new drug for rare diseases will be put on the market; 2 The most advantageous antipsychotics will be developed in Japan; 310 million potential broad-spectrum antibacterial drugs
-
$400 million in compensation! By Ranbaxy get a body of coquettish first three altogether finally get comfort
Time of Update: 2016-05-11
Source: medicine magic cube 2016-05-11 the first three obtained 54.8% equity of Ranbaxy company, the largest pharmaceutical company in India at that time, at the cost of US $4.6 billion in 2008, inclu
-
After clinical self examination, what should enterprises do
Time of Update: 2015-08-31
Source: sabilan / Zhao Dong, August 28, 2015, CFDA issued the notice of the State Food and Drug Administration on the self inspection of drug clinical trial data (No 169, 2015) No ", which marks the e
-
Zostavax's monopoly position is not guaranteed: the key phase III of GSK herpes zoster vaccine Hz / Su is a great success
Time of Update: 2014-12-19
Source: Biovalley, Dec 19, 2014: GSK herpes zoster vaccine Hz / Su achieved great success in key phase III Research (zoe-50) The vaccine is expected to increase the annual revenue of GSK's expanding v
